We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Fenofibrate and Pharmacogenetic Impact in Dyslipidemia (FPI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00613613
Recruitment Status : Completed
First Posted : February 13, 2008
Last Update Posted : December 3, 2014
Sponsor:
Collaborator:
Laval University
Information provided by (Responsible Party):
University of Minnesota - Clinical and Translational Science Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2013
  Study Completion Date : December 2013